Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01903395
Other study ID # NKP332-032
Secondary ID
Status Completed
Phase N/A
First received July 11, 2013
Last updated October 24, 2016
Start date March 2012
Est. completion date December 2015

Study information

Verified date October 2016
Source Martin-Luther-Universität Halle-Wittenberg
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Ministry of Education and Research
Study type Interventional

Clinical Trial Summary

BACKGROUND: First-degree relatives of patients with colorectal cancer are at increased risk for colorectal cancer as well. Nevertheless, participation in the German national screening program stagnates at 2-3 percent per year even in this high-risk population.

AIM: The study is aimed to increase the portion of the first-degree relatives on 50% which take up a preventive colonoscopy.

METHODS: Cluster-randomized controlled multi-center trial. Study sites (clusters) are mainly certified cancer centers and office-based gastroenterologists from all over Germany. Index-patients with colorectal cancer of different stages are asked to hand over the study material to their relatives, consisting of an invitation to a nurse-led counseling on preventive colonoscopy and an one-to-one appointment with a clinical expert of one of the study sites next.


Recruitment information / eligibility

Status Completed
Enrollment 313
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 45 Years and older
Eligibility Inclusion Criteria:

- aged 18 and over

- being first-degree relatives of patients with diagnosed colorectal cancer

- able to understand German

Exclusion Criteria:

- Familial Adenomatous Polyposis

- utilization of diagnostic colonoscopy within the past 5 years

- being ever treated for colorectal cancer

- actual inflammatory bowl disease

- comorbidities associated with reduced further life expectancy (ECOG performance status >3

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Nurse-led counselling
Nurse-led telephone counselling to double the utilization of preventive colonoscopy

Locations

Country Name City State
Germany Klinikum Aschaffenburg Aschaffenburg Bayern
Germany Krankenhaus St. Marienwörth Bad Kreuznach Rheinland-Pfalz
Germany Universitätsklinikum Knappschaftskrankenhaus Ruhr Universität Bochum Bochum Nordrhein-Wetsfalen
Germany Städtisches Klinikum Braunschweig Braunschweig Niedersachsen
Germany Allgemeines Krankenhaus Celle Celle Niedersachsen
Germany Diakonissenkrankenhaus Dessau gemeinnützige GmbH Dessau-Roßlau Sachsen-Anhalt
Germany Johanniter-Krankenhaus Rheinhausen Duisburg Nordrhein-Westfalen
Germany Klinikum Barnim Eberswalde Brandenburg
Germany Universitätsklinikum Erlangen Erlangen Bayern
Germany Sankt Elisabeth Hospital Gütersloh Gütersloh Nordrhein-Westfalen
Germany Klinikum Hanau Hanau Hessen
Germany Westküstenklinikum Heide Heide Schleswig-Holstein
Germany Universitätsklinikum Jena Jena Thüringen
Germany Klinik Evang. Krankenhaus Kalk Köln Nordrhein-Westfalen
Germany Krankenhaus Köln-Holweide Köln Nordrhein-Westfalen
Germany Evangelisches Diakonissenkrankenhaus Leipzig gGmbH Leipzig Sachsen
Germany Klinikum Lüdenscheid Lüdenscheid Nordrhein-Westfalen
Germany Klinikum Ludwigsburg Ludwigsburg Baden-Würtemberg
Germany Städtisches Klinikum Lüneburg Lüneburg Niedersachsen
Germany Evangelisches Krankenhaus Paul Gerhardt Stift Lutherstadt Wittenberg Sachsen-Anhalt
Germany Praxis für Innere Medizin Dr. med. Regine Lange Lutherstadt Wittenberg Sachsen-Anhalt
Germany Klinikum Magdeburg gemeinnützige GmbH Magdeburg Sachsen-Anhalt
Germany Diakoniekrankenhaus Mannheim Mannheim Baden-Würtemberg
Germany Universitätsklinikum Gießen und Marburg Marburg Hessen
Germany Klinikum Osnabrück GmbH Osnabrück Niedersachsen
Germany HELIOS Klinik Sangerhausen Sangerhausen Sachsen-Anhalt
Germany HELIOS Kliniken Schwerin Schwerin Mecklenburg-Vorpommern
Germany Kliniken Landkreis Sigmaringen GmbH Sigmaringen Baden-Württemberg
Germany Diakonissen-Stiftungs-Krankenhaus Speyer Speyer Rheinland-Pfalz
Germany Klinikum Stuttgart Krankenhaus Bad Cannstatt Stuttgart Baden-Würtemberg
Germany Universitätsklinikum Ulm Ulm Baden-Würtemberg
Germany Gastroenterologische Schwerpunktpraxis Völklingen Völklingen Saarland
Germany Stiftung Juliusspital Würzburg Würzburg Bayern

Sponsors (1)

Lead Sponsor Collaborator
Martin-Luther-Universität Halle-Wittenberg

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary utilization of preventive colonoscopy utilization within 30 days after enrolement Yes
Secondary Rate of advanced adenomas or carcinomas in situ Rate within 6 month after enrolement Yes
Secondary post-operative complications associated with the colonoscopy within 30 days after enrolement Yes
Secondary barriers to the use of preventive colonoscopy Barriers against preventive colonoscopy are very common among the healthy population. Such barriers can bei either of cognitive (e.g. being afraid of the potential diagnosis) or emotional nature (e.g. shame to be exposed naked to the examiners).
Barriers are assessed by Barriers Questionnaire-II (BQ-II) during telephone counselling.
within 30 day after enrolement, additional at 6 months after enrolement No
Secondary effectiveness and cost-effectiveness of nurse-led counselling within 30 days after enrolement No
Secondary time delay between signed informed consent and utilization of colonoscopy at utilization of the colonoscopy No
See also
  Status Clinical Trial Phase
Recruiting NCT04552093 - Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT) Phase 2/Phase 3
Completed NCT04192565 - A Prospective Investigation of the ColubrisMX ELS System N/A
Completed NCT05178745 - A Prospective Observational Cohort Study Evaluating Resection Rate in Patients With Metastatic Colorectal Cancer Treated With Aflibercept in Combination With FOLFIRI - Observatoire résection
Recruiting NCT03561350 - Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing
Recruiting NCT06128798 - Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery. N/A
Recruiting NCT03602677 - Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage N/A
Completed NCT03631407 - Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046) Phase 2
Withdrawn NCT04192929 - Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy N/A
Recruiting NCT03042091 - Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery Early Phase 1
Terminated NCT02842580 - De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer Phase 2
Completed NCT02889679 - Underwater Resection of Non-pedunculated Colorectal Lesions N/A
Completed NCT02564835 - Effects of Yoga on Cognitive and Immune Function in Colorectal Cancer N/A
Completed NCT02503696 - Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) N/A
Completed NCT02149108 - Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1) Phase 3
Completed NCT02599103 - The Effects of Various Cooking Oils on Health Related Biomarkers in Healthy Subjects N/A
Completed NCT01669109 - Hatha Yoga for Patients With Colorectal Cancer N/A
Completed NCT01719926 - Phase I Platinum Based Chemotherapy Plus Indomethacin Phase 1
Recruiting NCT01428752 - Study of Prevalence of Colorectal Adenoma in 30- to 49-year-old Subjects With a Family History of Colorectal Cancer N/A
Completed NCT01978717 - General Anesthesia Combined With Epidural Anesthesia Mitigates the Surgical Stress-related Immunosuppression in Patients With Colorectal Cancer N/A
Completed NCT01877018 - Colorectal Cancer Screening in Primary Care N/A